Németh, Z.; Pallagi, E.; Dobó, D.G.; Kozma, G.; Kónya, Z.; Csóka, I.
An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development. Pharmaceutics 2021, 13, 1071.
https://doi.org/10.3390/pharmaceutics13071071
AMA Style
Németh Z, Pallagi E, Dobó DG, Kozma G, Kónya Z, Csóka I.
An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development. Pharmaceutics. 2021; 13(7):1071.
https://doi.org/10.3390/pharmaceutics13071071
Chicago/Turabian Style
Németh, Zsófia, Edina Pallagi, Dorina Gabriella Dobó, Gábor Kozma, Zoltán Kónya, and Ildikó Csóka.
2021. "An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development" Pharmaceutics 13, no. 7: 1071.
https://doi.org/10.3390/pharmaceutics13071071
APA Style
Németh, Z., Pallagi, E., Dobó, D. G., Kozma, G., Kónya, Z., & Csóka, I.
(2021). An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development. Pharmaceutics, 13(7), 1071.
https://doi.org/10.3390/pharmaceutics13071071